NKGen Biotech Stock (NASDAQ:NKGN), Quotes and News Summary

Q: What sector and industry does NKGen Biotech (NKGN) operate in?

NKGen Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NKGen Biotech Stock (NASDAQ: NKGN) stock price, news, charts, stock research, profile.

Open	$1.900
Close	$1.610
Volume / Avg.	546.549K / 3.457M
Day Range	1.600 - 1.950
52 Wk Range	0.780 - 6.700
Market Cap	$37.173M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	-
Days to Cover	1

Recent News

What's Going On With Nano-Cap NKGen Biotech Stock On Monday?

Latest on NKGen Biotech Inc (NASDAQ: NKGN) as shares surge 25.2% on high volume. Insights into NK cell therapy for neurodegenerative diseases. Developments in Parkinson's and Alzheimer's treatments.

Vandana Singh

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About NKGen Biotech Inc

Sector

Health Care

Industry

Biotechnology

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and onc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NKGen Biotech (NKGN) stock?

You can purchase shares of NKGen Biotech (NASDAQ: NKGN) through any online brokerage.

View our list of the best stock brokerages.

Who are NKGen Biotech's (NKGN) competitors?

Other companies in NKGen Biotech’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immuneering (NASDAQ:IMRX).

What is the target price for NKGen Biotech (NKGN) stock?

There is no analysis for NKGen Biotech.

Current Stock Price for NKGen Biotech (NKGN)?

The stock price for NKGen Biotech (NASDAQ: NKGN) is $1.63 last updated April 26, 2024 at 7:58 PM EDT.

Does NKGen Biotech (NKGN) pay a dividend?

There are no upcoming dividends for NKGen Biotech.

When is NKGen Biotech (NASDAQ:NKGN) reporting earnings?

NKGen Biotech’s Q1 earnings are confirmed for Thursday, May 16, 2024.

Is NKGen Biotech (NKGN) going to split?

There is no upcoming split for NKGen Biotech.

What sector and industry does NKGen Biotech (NKGN) operate in?

NKGen Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-